The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: -3.00 (-0.65%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 462.00
Low: 462.00
Prev. Close: 465.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to AIM and First Day of Dealings

14 Jun 2018 07:00

RNS Number : 3144R
Aquis Exchange PLC
14 June 2018
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, SINGAPORE, HONG KONG, THE REPUBLIC OF SOUTH AFRICA, OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

This Announcement is not an admission document or a prospectus and should not be construed as an offer or form part of any offer to sell or issue, or solicitation of an offer to purchase or subscribe for, any of the securities mentioned in this Announcement nor should it or any part of it form the basis of, or be relied on in connection with, any contract or commitment whatsoever. In particular, these materials are not an offer of securities for sale in the United States. Investors should not subscribe for or purchase any transferable securities referred to in this Announcement except on the basis of information in the Admission Document published on 11 June 2018.

 

14 June 2018

 

 

AQUIS EXCHANGE PLC

 

("Aquis" or the "Company")

 

Admission to AIM and First Day of Dealings

 

 

Aquis Exchange PLC, the independent, pan-European equities exchange operator and technology service provider, is pleased to announce that admission of its shares to trading on the AIM market of the London Stock Exchange will take place and dealings will commence at 8.00 a.m. today under the ticker AQX and the ISIN GB00BD5JNK30.

 

The Company's Admission Document can be found at http://www.aquis.eu/.

 

Enquiries 

 

Aquis Exchange PLC

Alasdair Haynes, CEO

Jonathan Clelland, CFO and COO

 

Tel: +44 (0) 20 3597 6321

Liberum Capital Limited (Nominated Adviser and Broker)

Clayton Bush

Chris Clarke

Jill Li

Kane Collings

 

Tel: +44 (0) 20 3100 2000

Finsbury (Financial Public Relations)

Alastair Hetherington

Michael Turner

Alexander Gorokhov

Tel: +44 (0) 20 7251 3801

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFJMITMBTBBPP
Date   Source Headline
24th Apr 20207:00 amRNSPublication of ARA and Notice of AGM
20th Apr 20207:00 amRNSIssue of Options and Director/PDMR Notification
16th Apr 20207:00 amRNSFinal results
15th Apr 20207:00 amRNSExercise of Share Options & Total Voting Rights
24th Mar 20207:00 amRNSUpdate to Results Announcement Date
4th Mar 20203:49 pmRNSFCA Approval of NEX Exchange Acquisition
19th Dec 20197:00 amRNSTiming of NEX Exchange Acquisition,Trading Update
22nd Nov 20192:40 pmRNSDirector/PDMR Notification
17th Sep 20197:00 amRNSInterim results for six months ended 30 June 2019
28th Aug 20197:00 amRNSNotice of Results
5th Jul 20197:00 amRNSAcquisition of NEX Exchange
27th Jun 20195:57 pmRNSMarket Update
5th Jun 20197:00 amRNSAquis Exchange achieves record market share
30th Apr 20191:16 pmRNSResult of AGM
29th Mar 20197:00 amRNSPublication of Annual Report and Notice of AGM
20th Mar 20191:30 pmRNSConfirmation of Board Appointment
20th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
5th Mar 201911:00 amRNSAquis supplies AkinovA with trading technology
26th Feb 20194:38 pmRNSTR-1: Notification of major holdings
19th Feb 20197:00 amRNSTR-1: Notification of major holdings
24th Jan 20197:00 amRNSFrench Regulatory Approval
8th Jan 20197:00 amRNSTrading Update and Board Appointment
7th Jan 20192:14 pmRNSTR-1: Notification of major holdings
4th Dec 201811:13 amRNSAQUIS EXCHANGE RELEASE NOVEMBER TRADING STATISTICS
26th Nov 201811:10 amRNSStandard form for notification of major holdings
21st Nov 201810:17 amRNSDirector/PDMR Notification
16th Oct 20189:54 amRNSTR-1: Notification of major holdings
25th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
6th Sep 20187:00 amRNSTechnology Licensing Agreement
4th Sep 20185:19 pmRNSResult of General Meeting
13th Aug 20185:15 pmRNSNotice of General Meeting
4th Jul 20183:59 pmRNSTR-1: Notification of major holdings
14th Jun 20188:30 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.